Ares Management Corp. (ARES) Social Stream



Ares Management Corp. (ARES): $83.97

-0.65 (-0.77%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ARES to Watchlist
Sign Up

Featured Post From StockTwits About ARES

$OPGN A FUND, $SPY $QQQ, WILL DO VERY WELL IN THE 2'S: Risk/Reward the best I've ever seen: Company needs to issue guide, because the market doesn't understand the value here. Below is my summation; massively undervalued. Science is unsurpassed. Unyvero can identify and stop the next deadly pathogen. I believe, and please correct me if I'm wrong, that the CEO said that this is the most comprehensive test with 8000 markers? FDA PENDING/DUE IN THE NEXT 8 TRADING DAYS.
Math is as follows: OPGN ACQUIRES $ARES GENETICS & $CURETIS
$8 - $10 PER SHARE,
$OPGN secures deal with CDC/State of New York/35 Hospitals
$15 per share,
$OPGN inks a 8 year 181M deal with
$CHINA BIO $25 per share,
$OPGN signs deal with Columbia, and secures Menari Partnership $28, $OPGN achieves the equivalent of FDA in China, (GDP significant),
$OPGN Receives note from US FDA l is due now; August. $40-$50 per share. AT $2 TRADE IS ARTIFICALLY DEPRESSED AND MASSIVELY UNDERVALUED. BACK UP THE TRUCK
ChartHawk, published August 16, 2021

What Else are ARES Traders Talking About?


Other tickers frequently mentioned alongside ARES are OPGN, SPY and QQQ.

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5376 seconds.